Research Topics
Genomes and Genes | Joseph T RabbanSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinomaJoseph T Rabban
Department of Pathology, University of California, M 551 San Francisco, California 94143, USA
Am J Surg Pathol 33:1125-36. 2009....- Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovaryJoseph T Rabban
Department of Pathology, University of California San Francisco, San Francisco, California 94143, USA
Int J Gynecol Pathol 28:41-8. 2009.... - Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual diseaseJoseph T Rabban
Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
Am J Surg Pathol 33:256-63. 2009..D2-40 immunostaining is useful in this setting. Current staging criteria should be clarified to define whether extensive intralymphatic tumor should be incorporated in tumor stage assignment... - Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutationsJoseph T Rabban
Department of Pathology, Cancer Risk Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA
Am J Surg Pathol 33:111-9. 2009..This study demonstrates that transitional cell metaplasia of the fimbriae is a common benign finding in RRSO specimens that should not be confused with the much less common finding of tubal intraepithelial carcinoma... - Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocolJoseph T Rabban
Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA
Am J Surg Pathol 33:1878-85. 2009..Guidelines for evaluation of RRSO specimens should emphasize the use of an optimal dissection protocol and the importance of thin tissue slice intervals... - PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinomaJoseph T Rabban
Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, M 551, San Francisco, CA 94143, USA
Am J Surg Pathol 34:137-46. 2010..001); however, PAX2 should not be interpreted in isolation from the architectural and cytologic features of the lesion as it may be expressed in some stage II endometrial adenocarcinomas involving the cervix... - D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinomaJoseph T Rabban
Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
Hum Pathol 39:175-83. 2008..We recommend that myoepithelial markers be used in conjunction with D2-40 to distinguish solid intralymphatic tumor emboli from solid pattern in situ carcinoma... - Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumorJoseph T Rabban
Department of Pathology, University of California, San Francisco, CA 94143, USA
Gynecol Oncol 103:1164-8. 2006..The endometrial carcinoma is thought to occur under the influence of the estrogen receptor pathway and is typically a low-grade, low-stage endometrioid adenocarcinoma... - HMGA2 rearrangement in a case of vulvar aggressive angiomyxomaJoseph T Rabban
Department of Pathology, University of California, San Francisco, 94193, USA
Int J Gynecol Pathol 25:403-7. 2006..HMGA2 involvement has also been described in a variety of benign gynecologic mesenchymal neoplasms. We report an additional case of HMGA2 rearrangement in vulvar aggressive angiomyxoma, using fluorescence in situ hybridization... - Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markersJoseph T Rabban
Department of Pathology, University of California, San Francisco, CA 94143, USA
Mod Pathol 19:1351-7. 2006..Reliance on p63 or smooth muscle actin alone poses a potential diagnostic pitfall in evaluating cribriform breast lesions... - Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluationJoseph T Rabban
Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA
Gynecol Oncol 121:466-71. 2011..The aim of this study was to correlate the macroscopic and microscopic pathologic findings in RRSO... - Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6Joseph T Rabban
Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
Hum Pathol 37:787-93. 2006..Pathologists must guard against misinterpreting SP-DCIS as UDH in those cases in which the carcinoma cells engulf cytokeratin 5/6-expressing residual, native epithelial cells... - COMT polymorphisms affecting protein expression are risk factors for endometrial cancerHiroshi Hirata
Department of Urology, Veterans Affairs Medical Center and University of California at San Francisco, San Francisco, California 94121, USA
Mol Carcinog 47:768-74. 2008..This is the first study demonstrating that polymorphisms in COMT codon 62 and codon 158 altered protein expression levels in EC, suggesting that they may be risk factors for EC in Caucasians... - Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocolC Bethan Powell
Cancer Risk Program, Department of Pathology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA
Int J Gynecol Cancer 21:846-51. 2011..We report outcomes in 111 consecutive BRCA-positive women who had RRSO using a rigorous surgical-pathological protocol from 1996 to 2008... - Decidualized endometrioma during pregnancy: recognizing an imaging mimic of ovarian malignancyLiina Poder
Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
J Comput Assist Tomogr 32:555-8. 2008.... - Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysisElizabeth M Hosfield
Department of Pathology, University of California, San Francisco, California 94143, USA
Int J Gynecol Pathol 27:465-74. 2008..Dialysis-associated changes involving the ovary and fallopian tube form a mechanical barrier that could contribute to the low rate of fertility in peritoneal dialysis patients... - Superficial endometrial spread of squamous cell cervical carcinoma: a diagnostic challenge at magnetic resonance imagingFelix Adler
Department of Radiology, University of California, San Francisco, CA 94143 0628, USA
J Comput Assist Tomogr 31:247-50. 2007.... - Minimal uterine serous carcinoma: current concepts in diagnosis and prognosisJoseph T Rabban
University of California San Francisco, Department of Anatomic Pathology, San Francisco, CA 94143, USA
Pathology 39:125-33. 2007..We review the diagnostic criteria for minimal USC, pitfalls in the differential diagnosis, and discuss a practical approach to evaluating biopsies, polypectomies, or hysterectomies containing minimal USC... - Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instabilityAnıl Aysal
Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
Am J Surg Pathol 36:163-72. 2012..Thus, in patients with ovarian endometrioid adenocarcinoma who undergo uterus-sparing surgery, abnormal MMR/MSI should prompt further diagnostic evaluation of the endometrium for tumor... - CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibilityHiroshi Hirata
Department of Urology, University of California at San Francisco, San Francisco, CA 94121, USA
Cancer 112:1964-73. 2008..The authors hypothesized that single nucleotide polymorphisms (single nucleotide polymorphisms) of CYP1A1, CYP1A2, CYP1B1, CYP17, SULT1A1, SULT1E1, and SHBG genes may be risk factors for endometrial cancer... - Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumorsJoseph T Rabban
Department of Anatomic Pathology, University of California-San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
Am J Surg Pathol 29:1348-55. 2005..ALK expression appears to be of diagnostic value in conjunction with other immunohistochemical stains... - Current issues in the pathology of ovarian cancerJoseph T Rabban
Gillette Center in Women's Cancer Pathology and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Reprod Med 50:467-74. 2005..Special processing of the pathologic specimens is required to detect early and minimal neoplasia in this setting. These current issues in the pathology of ovarian carcinoma and their clinical significance form the basis of this review... - Sclerosing lesions of the breastJoseph T Rabban
James Homer Wright Pathology Laboratories, Molecular Pathology Unit, Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129, USA
Semin Diagn Pathol 21:42-7. 2004..Important diagnostic features of these lesions are highlighted and contrasted with those of invasive carcinoma...